Indego is made by Parker Hannifin Indego, based in Cleveland, OH.

Where is Indego deployed?

No verified deployments of Indego are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.

Indego has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Indego · DEPLOY

Name: Indego
Brand: Parker Hannifin Indego

Overview

Parker Hannifin's Indego is a powered lower-limb exoskeleton, FDA-cleared via 510(k) in 2016, intended to enable individuals with spinal cord injury at levels T7 to L5 to perform ambulatory functions with supervision of a specially trained companion.

Verified vs. claimed

Verified deployments: None on file
Sources on file: 1 source, view all

Safety record

No incidents on record for Indego.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (1)

https://www.southcarolinablues.com/web/public/brands/medicalpolicy/external-policies/powered-exoskeleton-for-ambulation-in-patients-with-lower-limb-disabilities/

Common questions

What is Indego?: Parker Hannifin's Indego is a powered lower-limb exoskeleton, FDA-cleared via 510(k) in 2016, intended to enable individuals with spinal cord injury at levels T7 to L5 to perform ambulatory functions with supervision of a specially trained companion.
Who makes Indego?: Indego is made by Parker Hannifin Indego, based in Cleveland, OH.
Where is Indego deployed?: No verified deployments of Indego are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
Is Indego safe?: Indego has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Methodology: Verified · 1 source (no primary) · last reviewed 2026-06-28

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-06-28

Maturity + lifecycle

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

1: unclassified; Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

No press coverage on file for Indego yet. Coverage appears here automatically as articles are ingested from our press sources.

Machine-readable surfaces

Markdown mirror: /models/parker-indego.md
JSON-LD: embedded in this page’s head
REST API: /v1/models/894204d2-44c2-4f9e-9261-5d64481f866a
Revision history: /models/parker-indego/history
Data documentation: /data
Query this programmatically: Deploy MCP

DEPLOY Intelligence Score

0.0/ 100

vs 6 months ago

6-month trend

Peer rankingTop 65% of Exoskeleton

Analysis

Thin deployment record; scale validation still in progress.

Signal flags

No new deployment (12 months)

Dimension breakdown

Safety Record

95.0LOW

Adoption Spread

16.723.3LOW

IP Activity

5.0LOW

Deployment Scale

0.0LOW

Market Presence

0.0LOW

DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.

Last computed: Jul 3, 2026

Intelligence layer